These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3019567)

  • 1. Regulation of rat natural killing. II. Inhibition of cytolysis and activation by inhibitors of lipoxygenase: possible role of leukotrienes.
    Leung KH; Ip MM
    Cell Immunol; 1986 Jul; 100(2):474-84. PubMed ID: 3019567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of human natural killing. IV. Role of lipoxygenase in regulation of natural killing activity.
    Leung KH; Ip MM; Koren HS
    Scand J Immunol; 1986 Oct; 24(4):371-80. PubMed ID: 3532301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of lipoxygenation in human natural killer cell activation.
    Bray RA; Brahmi Z
    J Immunol; 1986 Mar; 136(5):1783-90. PubMed ID: 3081633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Products of the lipoxygenase pathway in human natural killer cell cytotoxicity.
    Rossi P; Lindgren JA; Kullman C; Jondal M
    Cell Immunol; 1985 Jun; 93(1):1-8. PubMed ID: 2986854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible inhibition of lymphokine-activated killer cell activity by lipoxygenase-pathway inhibitors.
    Sibbitt WL; Imir T; Bankhurst AD
    Int J Cancer; 1986 Oct; 38(4):517-21. PubMed ID: 3019899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of leukotriene-induced contraction of guinea pig trachea by 5-lipoxygenase inhibitors.
    Schwalm SF; Lewis AJ; Hand JM
    Prostaglandins; 1987 Jan; 33(1):113-9. PubMed ID: 3108959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of rat natural killing. I. Inhibition of cytolysis and activation by protein synthesis inhibitors.
    Leung KH; Ip MM
    Int J Immunopharmacol; 1985; 7(6):857-63. PubMed ID: 4077345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of putative lipoxygenase inhibitors on arachidonic acid metabolism in cell-free and intact cell preparations.
    Chang J; Skowronek MD; Cherney ML; Lewis AJ
    Inflammation; 1984 Jun; 8(2):143-55. PubMed ID: 6430801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of putative inhibitors on cytosolic and membrane associated platelet lipoxygenase.
    Rao GH; Kishore NP; White JG
    Prostaglandins Leukot Med; 1987 Mar; 26(3):281-90. PubMed ID: 3106988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of steroid production in Leydig cells by non-steroidal anti-inflammatory and related compounds: evidence for the involvement of lipoxygenase products in steroidogenesis.
    Dix CJ; Habberfield AD; Sullivan MH; Cooke BA
    Biochem J; 1984 Apr; 219(2):529-37. PubMed ID: 6430271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of leukotriene C4 synthesis and natural killer activity by ethacrynic acid.
    Leung KH
    Cell Immunol; 1988 Jul; 114(2):359-69. PubMed ID: 3390866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arachidonic acid metabolism and casein secretion in lactating rabbit mammary epithelial cells: effects of inhibitors of prostaglandins and leukotrienes synthesis.
    Blachier F; Lacroix MC; Ahmed AM; Léger C; Ollivier-Bousquet M
    Prostaglandins; 1988 Feb; 35(2):259-76. PubMed ID: 2834771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further evidence for role of leukotrienes as mediators of decidualization in the rat.
    Tawfik OW; Dey SK
    Prostaglandins; 1988 Mar; 35(3):379-86. PubMed ID: 2836890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of a novel series of selective inhibitors of arachidonate 5-lipoxygenase on anaphylactic and inflammatory responses.
    Bhattacherjee P; Boughton-Smith NK; Follenfant RL; Garland LG; Higgs GA; Hodson HF; Islip PJ; Jackson WP; Moncada S; Payne AN
    Ann N Y Acad Sci; 1988; 524():307-20. PubMed ID: 2837965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential inhibition of 5-lipoxygenase activity by manoalide.
    De Vries GW; Amdahl L; Mobasser A; Wenzel M; Wheeler LA
    Biochem Pharmacol; 1988 Aug; 37(15):2899-905. PubMed ID: 2840081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of macrophage-derived fibroblast growth factor release by arachidonate metabolites.
    Phan SH; McGarry BM; Loeffler KM; Kunkel SL
    J Leukoc Biol; 1987 Aug; 42(2):106-13. PubMed ID: 3036988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of antioxidants on cyclooxygenase and lipoxygenase activities in intact human platelets: comparison with indomethacin and ETYA.
    Van Wauwe J; Goossens J
    Prostaglandins; 1983 Nov; 26(5):725-30. PubMed ID: 6422509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lipoxygenase pathway in the human NK cell system.
    Jondal M; Kullman C; Lindgren JA; Rossi P
    Adv Exp Med Biol; 1985; 184():257-70. PubMed ID: 2994411
    [No Abstract]   [Full Text] [Related]  

  • 19. Arachidonic acid metabolism in isolated pancreatic islets. III. Effects of exogenous lipoxygenase products and inhibitors on insulin secretion.
    Turk J; Colca JR; McDaniel ML
    Biochim Biophys Acta; 1985 Mar; 834(1):23-36. PubMed ID: 3919770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoxygenase pathway inhibition impairs the allograft response.
    Jordan ML; Carlson A; Hoffman RA; Simmons RL
    Surgery; 1987 Aug; 102(2):248-55. PubMed ID: 3039676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.